Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Dr David Dodwell

Dr David Dodwell

Contact information

Email
david.dodwell@ndph.ox.ac.uk

Telephone
01865 743562

David Dodwell

BSc, MD, FRCP, FRCR

Senior clinical research fellow, Consultant oncologist

David is a senior breast oncologist with a number of research and governance interests.

He is the lead oncologist on the Sloane and NHS breast screening audits and co-lead for the national audits in primary and metastatic breast cancer.

Recent publications

Eribulin for patients with metastatic breast cancer in England 2012-2021: Survival outcomes and 30-day mortality.

Wang Z. et al, (2026), Breast, 89

Evaluating breast cancer surgery ascertainment in England's routine healthcare data: A retrospective cohort study.

Wang L. et al, (2026), Cancer Epidemiol, 104

Clinicopathological, multimodal treatment, and survival patterns for men with breast cancer in England and Wales: a population-based cohort study.

Boyle JM. et al, (2026), EClinicalMedicine, 97

Real-world obesity prevalence and history in 79 271 patients receiving systemic anticancer therapy across 13 cancer types in England (2013-2023).

Perletta V. et al, (2026), ESMO Real World Data Digit Oncol, 12

Age, patient experience and satisfaction with breast cancer care: a cohort study using linked national cancer patient experience survey and cancer registry data.

Blacker S. et al, (2026), BMJ Open, 16

More publications